Neoplasms: all 9,616 studies

Page 31 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid TumorsTerminatedNCT02829723Phase 1/2Results posted
• A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung CancerTerminatedNCT02826161Phase 3Results posted
• Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced CancerCompletedNCT02823652Not applicableResults posted
• Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsCompletedNCT02810418Phase 1/2Results posted
• Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsCompletedNCT02808650Phase 1Results posted
• Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesCompletedNCT02807844Phase 1/2Results posted
• A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid TumorsCompletedNCT02799095Phase 1/2Results posted
• Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell MalignanciesCompletedNCT02795182Phase 1Results posted
• Exercise Prehab in Older Adults With Hematologic MalignanciesCompletedNCT02791737Not applicableResults posted
• Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsCompletedNCT02780804Phase 1Results posted
• Anti-NY ESO-1 mTCR Peripheral Blood LymphocytesTerminatedNCT02774291Early Phase 1Results posted
• Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile InfectionCompletedNCT02770326Not applicableResults posted
• Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid TumorsCompletedNCT02762981Phase 1/2Results posted
• Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)TerminatedNCT02761694Phase 1Results posted
• Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerCompletedNCT02759588Phase 1/2Results posted
• Study of Talimogene Laherparepvec In Children With Advanced Non CNS TumorsCompletedNCT02756845Phase 1Results posted
• Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid NeoplasmsCompletedNCT02756572Phase 2Results posted
• Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With CancerCompletedNCT02751827Results posted
• Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy VisitsCompletedNCT02751580Not applicableResults posted
• Pasireotide LAR Therapy of Silent Corticotroph Pituitary TumorsTerminatedNCT02749227Phase 2Results posted
• A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the UterusCompletedNCT02744898Phase 2Results posted
• Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesCompletedNCT02743351Phase 1/2Results posted
• Evaluate Use of Caudal Nerve Blocks in Adult Penile ProsthesisCompletedNCT02740127Phase 3Results posted
• Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery PathwayTerminatedNCT02740114Phase 3Results posted
• Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820TerminatedNCT02739360Phase 4Results posted
• A Study of LY2510924 and Durvalumab in Participants With Solid TumorsTerminatedNCT02737072Phase 1Results posted
• Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001)TerminatedNCT02731742Phase 1Results posted
• Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRTerminatedNCT02720185Phase 2Results posted
• A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid TumorsCompletedNCT02718911Phase 1Results posted
• Carvedilol in Preventing Heart Failure in Childhood Cancer SurvivorsCompletedNCT02717507Phase 2Results posted
• Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal MetastasesTerminatedNCT02715856Not applicableResults posted
• A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)CompletedNCT02711852Phase 2Results posted
• Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesTerminatedNCT02706392Phase 1Results posted
• Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChipTerminatedNCT02706197Not applicableResults posted
• PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)TerminatedNCT02702492Phase 1Results posted
• Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph NodesCompletedNCT02700386Phase 2Results posted
• Palliative Radiation Therapy in Reducing Pain in Patients With Bone MetastasisCompletedNCT02699697Not applicableResults posted
• Weekly BI 836880 in Patients With Advanced Solid TumorsCompletedNCT02689505Phase 1Results posted
• Brentuximab Vedotin in Relapsed/Refractory Germ Cell TumorsTerminatedNCT02689219Phase 2Results posted
• Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid TumorsCompletedNCT02686164Phase 1Results posted
• Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsCompletedNCT02684058Phase 2Results posted
• A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)CompletedNCT02684006Phase 3Results posted
• Dose Finding Study of BI 836880 in Patients With Solid TumorsCompletedNCT02674152Phase 1Results posted
• Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)TerminatedNCT02664961Phase 2Results posted
• A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsTerminatedNCT02663518Phase 1Results posted
• Administration of T Lymphocytes for Prevention of Relapse of LymphomasActive, not recruitingNCT02663297Phase 1Results posted
• The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid TumorsCompletedNCT02660034Phase 1Results posted
• T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesCompletedNCT02659943Phase 1Results posted
• PF-06671008 Dose Escalation Study in Advanced Solid TumorsTerminatedNCT02659631Phase 1Results posted
• Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mgCompletedNCT02651987Phase 2Results posted
• Sym015 (Anti-MET) in Patients With Advanced Solid Tumor MalignanciesCompletedNCT02648724Phase 1/2Results posted
• Non-Operative Radiation Management of Adenocarcinoma of the Lower RectumCompletedNCT02641691Phase 2Results posted
• Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose PhaseCompletedNCT02640755Phase 1Results posted
• Eribulin and Lenvatinib in Advanced Solid TumorsCompletedNCT02640508Phase 2Results posted
• Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid TumorsCompletedNCT02639546Phase 1/2Results posted
• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma WoundsCompletedNCT02638298Not applicableResults posted
• Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer SurvivorsCompletedNCT02613364Not applicableResults posted
• LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial CancerTerminatedNCT02612194Phase 2Results posted
• Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced MalignanciesTerminatedNCT02608268Phase 1/2Results posted
• A Study of Tazemetostat in Adult Participants With Soft Tissue SarcomaCompletedNCT02601950Phase 2Results posted
• EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial SarcomaCompletedNCT02601937Phase 1Results posted
• Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerCompletedNCT02595866Phase 1Results posted
• A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid TumorsCompletedNCT02593786Phase 1/2Results posted
• Dose-escalation Study of Birinapant and Pembrolizumab in Solid TumorsTerminatedNCT02587962Phase 1/2Results posted
• Study of INCB053914 in Subjects With Advanced MalignanciesTerminatedNCT02587598Phase 1/2Results posted
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedNCT02585713Phase 3Results posted
• Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02583269Phase 1Results posted
• Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms TumorsTerminatedNCT02581384Phase 1/2Results posted
• Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerTerminatedNCT02569957Phase 2Results posted
• BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid MalignanciesCompletedNCT02569476Phase 1Results posted
• Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02565901Phase 1/2Results posted
• Study of DS-8201a in Subjects With Advanced Solid Malignant TumorsCompletedNCT02564900Phase 1Results posted
• A Study of Ramucirumab (LY3009806) in Children With Refractory Solid TumorsCompletedNCT02564198Phase 1Results posted
• Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib AloneCompletedNCT02562755Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsCompletedNCT02555878Phase 3Results posted
• A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)TerminatedNCT02554812Phase 1/2Results posted
• Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)TerminatedNCT02553499Phase 1Results posted
• LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology OutpatientsTerminatedNCT02542397Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid TumorsTerminatedNCT02541604Phase 1/2Results posted
• Study of E7046 in Subjects With Selected Advanced MalignanciesTerminatedNCT02540291Phase 1Results posted
• Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid TumorsCompletedNCT02533674Phase 1Results posted
• A Study of LY3076226 in Participants With Advanced or Metastatic CancerCompletedNCT02529553Phase 1Results posted
• Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by SurgeryCompletedNCT02527304Not applicableResults posted
• Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver FunctionCompletedNCT02521376Phase 1Results posted
• BI 894999 First in Human Dose Finding Study in Advanced MalignanciesCompletedNCT02516553Phase 1Results posted
• (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid TumorsCompletedNCT02508532Phase 1Results posted
• A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid TumorsCompletedNCT02501096Phase 1/2Results posted
• Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorCompletedNCT02500550Phase 2Results posted
• Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell TumorsTerminatedNCT02499952Phase 2Results posted
• Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerCompletedNCT02499835Phase 1/2Results posted
• A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid TumorsCompletedNCT02494596Phase 1Results posted
• A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological DisordersCompletedNCT02494258Phase 2Results posted
• A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)CompletedNCT02493751Phase 1Results posted
• A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291CompletedNCT02491944Phase 1Results posted
• Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced CancerActive, not recruitingNCT02491632Phase 2/3Results posted
• A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid TumorsCompletedNCT02490475Phase 1Results posted
• An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored StudyCompletedNCT02488330Phase 3Results posted
• Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell CancersCompletedNCT02487095Phase 1/2Results posted
• Evaluating Strategies to Present Colon Cancer Screening InformationCompletedNCT02485561Not applicableResults posted

← Neoplasms overview